drinking on retatrutide Researchers are reporting that GLPs such as reduce alcohol cravings & consumption. This study mice support what researchers in the field have been reporting for awhile… Link to study: http://biorxiv.org/content/10.1101/2025.04.17.649402 What Is Retatrutide (Triple-G)? Weight

Description

This makes them more effective than traditional appetite suppressants that rely on stimulatory pathways

For most adults with type 2 diabetes, an HbA1c target of 48 mmol/mol (6.5%) is appropriate if achievable without causing problematic hypoglycaemia

Phase 2 Metabolic Benefits Beyond weight loss, retatrutide improved cardiometabolic markers: Blood pressure: Systolic BP decreased 7.4 mmHg (12mg dose) Triglycerides: Reduced 27% from baseline Fasting glucose: Decreased 13.8 mg/dL HbA1c: Reduced 0.4% (in participants without diabetes) TRIUMPH-4: Phase 3 Breakthrough (December 2025) TRIUMPH-4 was the first Phase 3 trial to report

Diabetes Metab Syndr Obes (2020) 13:307587

Recently, agonists of glucagon-like peptide-1 (GLP-1) receptor, designed based on the gut hormone GLP-1, have been developed as anti-obesity drugs and have demonstrated remarkable efficacy in treating both obesity and diabetes